Status:
COMPLETED
Personalized Nutrition Caffeine Intake in Healthy Adults.
Lead Sponsor:
Poznan University of Life Sciences
Conditions:
CYP1A2 Polymorphism
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Personalized nutrition is one of the most up to date trends in human nutrition and gains much interest of general public and scientists as well. Although we have gained some knowledge on gene-trait as...
Detailed Description
Considering current knowledge and recognizing the existing gaps we hypothesize that providing genotype information may increase adherence to dietary recommendations. The main aim of the project is th...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- age 18-60
- daily coffee intake at a minimum 2 cups (or equivalent total caffeine intake)
- Exclusion criteria:
- injuries,
- chronic diseases (e.g. diabetes, metabolic syndrome, cancer, hyperthyroidism),
- recent dieting,
- pregnancy or breastfeeding,
- no caffeine intake,
- taking chronic pain management pills which contain caffeine.
Exclusion
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 17 2021
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04122053
Start Date
October 1 2019
End Date
February 17 2021
Last Update
February 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poznan University of Life Sciences
Poznan, Poland